Dr Reddy’s Steps Into 'Must-Be' Medical Cannabis Segment With German Deal

Dr Reddy’s enters high-potential medical cannabis fray with the acquisition of Nimbus Health in Germany. The segment has seen a flurry of activity over the recent past, including the $7.2bn acquisition of pioneer GW Pharmaceuticals.

biz challenge
Dr Reddy's tiptoes into medicinal cannabis arena • Source: Alamy

Dr. Reddy's Laboratories Ltd. has delivered on its intent to sew up acquisitions across multiple key international markets, kicking off with a deal to buy German medical cannabis firm Nimbus Health GmbH.

The Indian company joins a growing pharma line-up keen to tap into a segment that has seen significant traction following...

More from Business

More from Scrip

IPO Update: With Just Two Small Offerings In Q2, What’s Next?

 
• By 

With low valuations for biopharma companies that recently went public and little hope of a near-term turnaround as uncertainty lingers, IPO numbers may stay low for the rest of 2025.

Actuate Is Looking For A Buyer To Advance Pancreatic Cancer Candidate

 

After presenting encouraging Phase II data on the GSK-3 inhibitor elraglusib at ASCO, Actuate Therapeutics is hoping to hold a pre-NDA meeting with the US FDA.

Novartis Upbeat Even With Entresto Expiry Looming

 
• By 

Swiss major confident that new oncology drugs will fill revenue gap.